Vicarious Surgical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2019
Selling, General & Admin	17.37	26.4	33.09	36.18	16.16	Upgrade
Research & Development	33.6	40.16	47.58	43.9	22.06	Upgrade
Operating Expenses	50.97	66.56	80.67	80.08	38.22	Upgrade
Operating Income	-50.97	-66.56	-80.67	-80.08	-38.22	Upgrade
Interest Expense	-	-	-0.03	-0.2	-0.09	Upgrade
Interest & Investment Income	0.97	3.29	4.43	1.44	0.02	Upgrade
Other Non Operating Income (Expenses)	0.79	0.04	5.19	84	3.09	Upgrade
EBT Excluding Unusual Items	-49.21	-63.22	-71.07	5.16	-35.21	Upgrade
Gain (Loss) on Sale of Assets	-1.92	-	-	-	-	Upgrade
Other Unusual Items	0.94	-	-	-	-	Upgrade
Pretax Income	-50.18	-63.22	-71.07	5.16	-35.21	Upgrade
Net Income	-50.18	-63.22	-71.07	5.16	-35.21	Upgrade
Net Income to Common	-50.18	-63.22	-71.07	5.16	-35.21	Upgrade
Shares Outstanding (Basic)	6	6	5	4	3	Upgrade
Shares Outstanding (Diluted)	6	6	5	4	3	Upgrade
Shares Change (YoY)	4.16%	20.93%	14.49%	31.89%	22.80%	Upgrade
EPS (Basic)	-8.19	-10.74	-14.60	1.27	-10.92	Upgrade
EPS (Diluted)	-8.19	-10.74	-14.60	1.20	-10.92	Upgrade
Free Cash Flow	-45.21	-50.14	-63.98	-66.56	-34.59	Upgrade
Free Cash Flow Per Share	-7.37	-8.52	-13.14	-15.66	-10.73	Upgrade
EBITDA	-49.54	-64.45	-78.81	-78.97	-37.91	Upgrade
D&A For EBITDA	1.43	2.11	1.85	1.11	0.32	Upgrade
EBIT	-50.97	-66.56	-80.67	-80.08	-38.22	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.